Cannabidiol Promotes Neuronal Differentiation Using Akt and Erk Pathways Triggered by Cb1 Signaling.

Area of Science:

• Neuroscience
• Pharmacology
• Cell Biology

Background:

• Cannabinoids, including cannabidiol (CBD), are gaining attention for their neurogenic potential.
• CBD exhibits concentration-dependent signaling through cannabinoid receptor 1 (CB1).

Purpose of the Study:

• To investigate the in vitro effects of CBD on neuronal differentiation.
• To explore the role of CB1 signaling in CBD-induced neurogenesis.

Main Methods:

• Utilized the NSC-34 hybrid cell line for in vitro studies.
• Analyzed gene expression profiles using high-throughput sequencing.
• Determined protein levels via Western blot assays.

Main Results:

• CBD treatment at 5 µM and 10 µM induced statistically significant changes in neurodifferentiation-associated genes (Rbfox3, Tubb3, Pax6, Eno2).
• CB1 signaling mediated neuronal differentiation at 10 µM CBD, evidenced by increased p-ERK and p-AKT.
• No significant CB1 pathway involvement was observed at 5 µM CBD.

Conclusions:

• CBD can induce in vitro neuronal differentiation in a concentration-dependent manner.
• CB1 receptor signaling is crucial for CBD-mediated neurogenesis at 10 µM.
• A novel correlation between CBD, neurodifferentiation, and retinoic acid receptor-related orphan receptors (RORs) was identified.